Bullish
bioAffinity Technologies announced promising preclinical results for its novel siRNA treatment, showing it selectively destroys squamous and basal ski...
Neutral
bioAffinity Technologies, Inc. has priced a public offering to raise $3.2 million. The offering includes 4,000,000 shares of common stock at $0.80 per...
Bearish
bioAffinity Technologies is conducting a public offering of 4 million shares of common stock (or pre-funded warrants) at $0.80 per share, aiming to ra...
Neutral
WallachBeth Capital LLC announced the pricing of a public offering for bioAffinity Technologies, Inc., a biotechnology company focused on noninvasive ...
BioAffinity Technologies has announced the pricing of a $3.2 million offering, which subsequently led to a 13% drop in its share price. The company sp...
bioAffinity Technologies announced a public offering worth $3.2 million, consisting of 4,000,000 shares of common stock at $0.80 per share or pre-fund...